Expert Opinion on Drug Metabolism & Toxicology, Volume 16, Issue 2 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Metabolism & Toxicology, Volume 16, Issue 2 (2020)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Volume 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Review

Review
Pharmacodynamics of current and emerging PD-1 and PD-L1 inhibitors for the treatment of non-small cell lung cancer
Danilo Rocco, Umberto Malapelle, Marzia Del Re, Luigi Della Gravara, Francesco Pepe, Romano Danesi, Giancarlo Troncone & Cesare Gridelli
Pages: 87-96
Published online: 30 Jan 2020
AbstractforPharmacodynamics of current and emerging PD-1 and PD-L1 inhibitors for the treatment of non-small cell lung cancer | Full Text | References | PDF (772.2 KB) | EPUB
  • 672 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
PK/PD and antiviral activity of anti-HCV therapy: is there still a role in the choice of treatment?
Valentina Zuccaro, Andrea Lombardi, Erika Asperges, Paolo Sacchi & Raffaele Bruno
Pages: 97-101
Published online: 31 Jan 2020
AbstractforPK/PD and antiviral activity of anti-HCV therapy: is there still a role in the choice of treatment? | Full Text | References | PDF (477.9 KB) | EPUB
  • 259 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Gender specific pharmacokinetic and pharmacodynamic considerations for antimuscarinic drugs for overactive bladder treatment
Siobhan M. Hartigan & Roger R. Dmochowski
Pages: 103-110
Published online: 14 Jan 2020
AbstractforGender specific pharmacokinetic and pharmacodynamic considerations for antimuscarinic drugs for overactive bladder treatment | Full Text | References | PDF (639.9 KB) | EPUB
  • 205 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
The continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive review
Ahmed B. Bayoumy, Melek Simsek, Margien L. Seinen, Chris J.J. Mulder, Azhar Ansari, Godefridus J. Peters & Nanne K. De Boer
Pages: 111-123
Published online: 24 Feb 2020
AbstractforThe continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive review | Full Text | References | PDF (1.2 MB) | EPUB
  • 4757 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Review
Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic
Rajiv Balyan, David Hahn, Henry Huang & Vidya Chidambaran
Pages: 125-141
Published online: 24 Feb 2020
AbstractforPharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic | Full Text | References | PDF (1.2 MB) | EPUB
  • 577 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
A review of the pharmacokinetics of M3 muscarinic receptor antagonists used for the treatment of asthma
Maria Gabriella Matera, Barbara Rinaldi, Carmela Berardo, Michele Rinaldi & Mario Cazzola
Pages: 143-148
Published online: 30 Jan 2020
AbstractforA review of the pharmacokinetics of M3 muscarinic receptor antagonists used for the treatment of asthma | Full Text | References | PDF (624.6 KB) | EPUB
  • 494 Views
  • 15 CrossRef citations
  • 0Altmetric
Review
Use of imaging to assess the activity of hepatic transporters
Irene Hernández Lozano & Oliver Langer
Pages: 149-164
Published online: 23 Jan 2020
AbstractforUse of imaging to assess the activity of hepatic transporters | Full Text | References | PDF (1.5 MB) | EPUB
  • 1983 Views
  • 15 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Understanding the impact of ABCG2 Polymorphisms on Drug Pharmacokinetics:Focus on rosuvastatin and allopurinol
Anne Kasten et al.
Review Article | Published online: 29 May 2024
Genetic polymorphisms of drug-metabolizing enzymes in older and Newer Anti-Seizure Medications
Gianluca D’Onofrio et al.
Editorial | Published online: 29 May 2024
Free Access
Recent progress in machine learning approaches for predicting carcinogenicity in drug development
Nguyen Quoc Khanh Le et al.
Review Article | Published online: 27 May 2024
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact
Lorenzo Gasperoni et al.
Review Article | Published online: 22 May 2024
Open Access
View all latest articles